From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
The Hepatitis B Prescriber Forum is a half-day forum designed for hepatitis B s100 prescribers that will cover current and relevant sector priorities and topics.
4 CPD hours
No upcoming sessions that suit you? Express your interest to be notified if a course is planned in your area.
With expert panels and interactive case discussions, the Hepatitis B Prescriber Forum is an opportunity to dive deep into emerging areas of hepatitis B treatment and management and discuss the contemporary issues facing hepatitis B clinical care in Australia.
On completion of this course, participants will be able to:
This is an RACGP-approved CPD activity under the RACGP CPD Program (4 Educational Activity Hours).
This event has been accredited in the 2026 – 2028 ACRRM CPD Program.
This activity is endorsed by the Australian College of Nurse Practitioners (ACNP) for 4 CPD hours.
HBV s100 prescribers will receive 2 HBV Prescriber Points for attending the Hepatitis B Prescriber Forum. By submitting and discussing your case study, you can receive an additional HBV Prescriber Point, totalling 3 HBV Prescriber Points (your full HBV Prescriber Point requirement for the year).
Hepatitis B s100 GP and NP Prescribers, Sexual Health Registrars and Physicians, Infectious Diseases Trainees and Physicians, and medical practitioners who are interested in prescribing Hepatitis B s100 medication and managing patients living with hepatitis B.
Enhance your clinical decision-making in hepatitis B management with this comprehensive resource. Stay updated and follow the guide to inform decisions in hepatitis B care by accessing this decision making guide.
The fourth edition of B positive has been updated to ensure consistency with the most recent Australian consensus recommendations for the management of hepatitis B (2022).
This form is a platform through which s100 prescribers can submit cases and questions to seek specialist review and advice.
In this 90-minute case discussion, participants will discuss a range of hepatitis B case studies with a specialist or experienced hepatitis B s100 prescriber, highlighting approaches to diagnosing, treating and managing people living with hepatitis B.
Supporting Clients with Legal Issues: Practical Skills for the BBV Healthcare Workforce, E-learning is designed to empower clinicians and health workers to identify common legal issues experienced by people living with blood-borne viruses (BBVs) and connect them with appropriate legal services. This E-learning was developed in partnership with Health + Law.
The Hepatitis B Prescriber Forum is a half-day forum designed for hepatitis B s100 prescribers that will cover current and relevant sector priorities and topics.
Are you passionate about educating other healthcare professionals on your area of expertise?
Express your interest in speaking at future ASHM courses
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM